GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgenic Group Inc (TSE:2342) » Definitions » Total Payout Ratio

Transgenic Group (TSE:2342) Total Payout Ratio : 0.00 (As of Apr. 12, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Transgenic Group Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Transgenic Group's current Total Payout Ratio is 0.00.


Transgenic Group Total Payout Ratio Historical Data

The historical data trend for Transgenic Group's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgenic Group Total Payout Ratio Chart

Transgenic Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.13 -0.30 3.77

Transgenic Group Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Transgenic Group's Total Payout Ratio

For the Biotechnology subindustry, Transgenic Group's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgenic Group's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Transgenic Group's Total Payout Ratio falls into.


;
;

Transgenic Group Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Transgenic Group's Total Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-78.617 + 0 + -83.818) / 43.081
=3.77

Transgenic Group's Total Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transgenic Group Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Transgenic Group's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgenic Group Business Description

Traded in Other Exchanges
N/A
Address
1-7-1 Yurakucho, Yurakucho Denki Building South Wing 4th Floor, Chiyoda-ku, Kobe-shi, JPN, 100-0006
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals.

Transgenic Group Headlines

No Headlines